Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients
Status:
Completed
Trial end date:
2019-05-15
Target enrollment:
Participant gender:
Summary
The study is designed to approve non-inferior efficacy and safety of Insulin RinGlar®
compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients.